Clinical Trials Browser

NIH × Melanoma × tanespimycin × Clear all

NCT00104897 2013-06-26

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Malignant Melanoma

Phase 2 Completed

Melanoma

NCT00087386 2013-04-10

Tanespimycin in Treating Patients With Stage III-IV Melanoma

Phase 2 Terminated

Melanoma